COGT
NASDAQ
$38.30
Cogent Biosciences Inc (COGT)
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $54.25 (+41.64%)
Market Cap
$6.71B
FCF 5Y CAGR
+48.74%
Free Cash Flow Yield
-4.27%
Beta (5Y)
1.71
Price Chart
Valuation
Market Cap$6.71B
P/S861.15
P/B12.13
Profitability
Gross Profit (TTM)-$122M
EBITDA-$359M
EPS-$2.43
Financial Health
Debt-to-Equity36.7%
Free Cash Flow Yield-4.27%
Growth & Risk
EPS 5Y CAGR-15.32%
FCF 5Y CAGR+48.74%
Beta (5Y)1.71
Sharpe Ratio1.27